heidi Zweers

Dr. heidi Zweers

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2021 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
HZheidi Zweers
heidi Zweers
AWAnnemiek M. J. van Wegberg
Annemiek M. J. van Wegberg
MJMirian C. H. Janssen
Mirian C. H. Janssen
SWSaskia B. Wortmann
Saskia B. Wortmann
Background: No curative therapy for mitochondrial disease (MD) exists, prioritizing supportive treatment for symptom relief. In animal and cell models ketones decrease oxidative stress, increase antioxidants and scavenge free radicals, putting ketogenic diets (KDs) on the list of management options for MD. Furthermore, KDs are well-known, safe and effective treatments for epilepsy, a frequent symptom of MD. This systematic review evaluates efficacy and safety of KD for MD. Methods: We searched Pubmed, Cochrane, Embase and Cinahl (November 2020) with search terms linked to MD and KD. From the identified records, we excluded studies on Pyruvate Dehydrogenase Complex deficiency. From these eligible reports, cases without a genetically confirmed diagnosis and cases without sufficient data on KD and clinical course were excluded. The remaining studies were included in the qualitative analysis. Results: Only 20 cases (14 pediatric) from the 694 papers identified met the inclusion criteria (one controlled trial (n = 5), 15 case reports). KD led to seizure control in 7 out of 8 cases and improved muscular symptoms in 3 of 10 individuals. In 4 of 20 cases KD reversed the clinical phenotype (e.g. cardiomyopathy, movement disorder). In 5 adults with mitochondrial DNA deletion(s) related myopathy rhabdomyolysis led to cessation of KD. Three individuals with POLG mutations died while being on KD, however, their survival was not different compared to individuals with POLG mutations without KD. Conclusion: Data on efficacy and safety of KD for MD is too scarce for general recommendations. KD should be considered in individuals with MD and therapy refractory epilepsy, while KD is contraindicated in mitochondrial DNA deletion(s) related myopathy. When considering KD for MD the high rate of adverse effects should be taken into account, but also spectacular improvements in individual cases. KD is a highly individual management option in this fragile patient group and requires an experienced team. To increase knowledge on this—individually—promising management option more (prospective) studies using adequate outcome measures are crucial.

25 January 2018 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
APAlex Pinto
Alex Pinto
MAMajid Alfadhel
Majid Alfadhel
RAR. Akroyd
R. Akroyd
YAyasemin atik altinok
yasemin atik altinok
SBS. M. Bernabei
S. M. Bernabei
Anita MacDonaldAnita MacDonald
Anita MacDonald
In fructose 1,6 bisphosphatase (FBPase) deficiency, management aims to prevent hypoglycaemia and lactic acidosis by avoiding prolonged fasting, particularly during febrile illness. Although the need for an emergency regimen to avoid metabolic decompensation is well established at times of illness, there is uncertainty about the need for other dietary management strategies such as sucrose or fructose restriction. We assessed international differences in the dietary management of FBPase deficiency. A cross-sectional questionnaire (13 questions) was emailed to all members of the Society for the Study of Inborn Errors of Metabolism (SSIEM) and a wide database of inherited metabolic disorder dietitians. Thirty-six centres reported the dietary prescriptions of 126 patients with FBPase deficiency. Patients’ age at questionnaire completion was: 1-10y, 46% (n = 58), 11-16y, 21% (n = 27), and >16y, 33% (n = 41). Diagnostic age was: 16y, 2% (n = 2). Seventy-five per cent of centres advocated dietary restrictions. This included restriction of: high sucrose foods only (n = 7 centres, 19%); fruit and sugary foods (n = 4, 11%); fruit, vegetables and sugary foods (n = 13, 36%). Twenty-five per cent of centres (n = 9), advised no dietary restrictions when patients were well. A higher percentage of patients aged >16y rather than ≤16y were prescribed dietary restrictions: patients aged 1-10y, 67% (n = 39/58), 11-16y, 63% (n = 17/27) and >16y, 85% (n = 35/41). Patients classified as having a normal fasting tolerance increased with age from 30% in 1-10y, to 36% in 11-16y, and 58% in >16y, but it was unclear if fasting tolerance was biochemically proven. Twenty centres (56%) routinely prescribed uncooked cornstarch (UCCS) to limit overnight fasting in 47 patients regardless of their actual fasting tolerance (37%). All centres advocated an emergency regimen mainly based on glucose polymer for illness management. Although all patients were prescribed an emergency regimen for illness, use of sucrose and fructose restricted diets with UCCS supplementation varied widely. Restrictions did not relax with age. International guidelines are necessary to help direct future dietary management of FBPase deficiency.

1 December 2013 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
SAS. Adam
S. Adam
Manuela Ferreira de AlmeidaManuela Ferreira de Almeida
Manuela Ferreira de Almeida
EWE. Carbasius Weber
E. Carbasius Weber
HCH. Champion
H. Champion
HCHsiao-Lung Chan
Hsiao-Lung Chan
HZheidi Zweers
heidi Zweers

18 December 2017 in Journal of Parenteral and Enteral Nutrition
Verified
Journal Article
Open access
HZheidi Zweers
heidi Zweers
MJMirian C. H. Janssen
Mirian C. H. Janssen
SLSusanne Leij
Susanne Leij
GWGeert Wanten
Geert Wanten
Background: Mitochondrial disease (MD) is a group of disorders caused by dysfunctional mitochondria, the organelles that generate energy for the cell. Malnutrition in patients with MD may lead to increased mitochondrial dysfunction, which may enhance already existing symptoms. The aim of this study was to investigate whether patients with MD have an insufficient or unbalanced food intake and to establish which nutrients and product groups are particularly compromised in this patient group. Methods: In this observational, cross‐sectional, retrospective study, sixty 3‐day nutrition diaries of adult patients with MD were analyzed and compared with the Dutch recommended daily allowance and the Dutch National Food Consumption Survey (DNFCS). Results: The intake of all macronutrients and micronutrients of patients with MD was significantly different from Dutch recommended daily allowance values with the exception of fat and iron. In particular, protein and calcium intake in patients with MD was significantly lower when compared with the DNFCS. Interindividual differences were high. Also, intake of fiber, sugars, saturated fat, and vitamin D differed from recommendations for the overall population. In comparison with DNFCS, the intake of dairy products and drinks was significant lower in patients. Conclusions: Our study demonstrates that many patients with MD have an inadequate diet. Specifically, intake of protein, calcium, dairy products, and fluids were low. Overall, eating a healthy diet seems as difficult for patients with MD as for the general population. Since interindividual differences are high, individual diet counseling is recommended for all adult patients with MD.

1 January 2015
Verified
Journal Article
Closed access
PLPaul de Laat
Paul de Laat
HZheidi Zweers
heidi Zweers
SKS Knuijt
S Knuijt
JSJ A M Smeitink
J A M Smeitink
GWG J A Wanten
G J A Wanten
MJM C H Janssen
M C H Janssen

1 May 2015 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
SAS. Adam
S. Adam
RAR. Akroyd
R. Akroyd
SBS. Bernabei
S. Bernabei
SBS. Bollhalder
S. Bollhalder
SBS. Boocock
S. Boocock
HZheidi Zweers
heidi Zweers